These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19630574)

  • 1. Hypereosinophilic syndrome: current approach to diagnosis and treatment.
    Klion A
    Annu Rev Med; 2009; 60():293-306. PubMed ID: 19630574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the diagnosis and treatment of hypereosinophilic syndromes.
    Klion AD
    Hematology Am Soc Hematol Educ Program; 2005; ():209-14. PubMed ID: 16304382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in classification of hypereosinophilic syndrome --- review].
    An ZM; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):1087-91. PubMed ID: 21867650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How I treat hypereosinophilic syndromes.
    Klion AD
    Blood; 2009 Oct; 114(18):3736-41. PubMed ID: 19692700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical management of the hypereosinophilic syndromes.
    Cogan E; Roufosse F
    Expert Rev Hematol; 2012 Jun; 5(3):275-89; quiz 290. PubMed ID: 22780208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypereosinophilic syndrome: approach to treatment in the era of precision medicine.
    Klion A
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):326-331. PubMed ID: 30504328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How I treat hypereosinophilic syndromes.
    Klion AD
    Blood; 2015 Aug; 126(9):1069-77. PubMed ID: 25964669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical overview of cutaneous features in hypereosinophilic syndrome.
    Plötz SG; Hüttig B; Aigner B; Merkel C; Brockow K; Akdis C; Darsow U; Ring J
    Curr Allergy Asthma Rep; 2012 Apr; 12(2):85-98. PubMed ID: 22359067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypereosinophilic syndrome: diagnosis and treatment.
    Peros-Golubicić T; Smojver-Jezek S
    Curr Opin Pulm Med; 2007 Sep; 13(5):422-7. PubMed ID: 17940488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypereosinophilic syndromes: pathogenic and therapeutic up-to-date].
    Kahn JE; Grandpeix-Guyodo C; Ackermann F; Charles P; Legrand F; Blétry O
    Rev Med Interne; 2010 Apr; 31(4):268-76. PubMed ID: 20303627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypereosinophilic syndrome].
    Troelsen LN; Boisen LW; Andersen O
    Ugeskr Laeger; 2005 Dec; 167(49):4663-4. PubMed ID: 16336860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypereosinophilic syndrome and proliferative diseases.
    Ionescu MA; Wang L; Janin A
    Acta Dermatovenerol Croat; 2009; 17(4):323-30. PubMed ID: 20021987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypereosinophilic syndrome: an update.
    Wilkins HJ; Crane MM; Copeland K; Williams WV
    Am J Hematol; 2005 Oct; 80(2):148-57. PubMed ID: 16184589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib mesylate for the treatment of hypereosinophilic syndromes.
    Antoniu SA
    Curr Opin Investig Drugs; 2006 Nov; 7(11):980-4. PubMed ID: 17117585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypereosinophilic syndrome presenting as an unusual triad of eosinophilia, severe thrombocytopenia, and diffuse arterial thromboses, with good response to mepolizumab.
    Leon-Ferre RA; Weiler CR; Halfdanarson TR
    Clin Adv Hematol Oncol; 2013 May; 11(5):317-9. PubMed ID: 23880717
    [No Abstract]   [Full Text] [Related]  

  • 16. An 8-year-old boy with hypereosinophilic syndrome.
    Hosoki K; Nagao M; Iguchi K; Ihara T; Yamada Y; Higashigawa M; Kephart GM; Kita H; Fujisawa T
    Int Arch Allergy Immunol; 2011; 155 Suppl 1():117-22. PubMed ID: 21646806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloproliferative hypereosinophilic syndrome presenting as cardiac failure and response to imatinib.
    Desai N; Morkhandikar S; Sahay R; Jijina F; Patil P
    Am J Ther; 2014; 21(2):e35-7. PubMed ID: 24603276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hypereosinophilic syndromes: still more heterogeneity.
    Gleich GJ; Leiferman KM
    Curr Opin Immunol; 2005 Dec; 17(6):679-84. PubMed ID: 16214314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in diagnosis and treatment of eosinophilia.
    Sheikh J; Weller PF
    Curr Opin Hematol; 2009 Jan; 16(1):3-8. PubMed ID: 19057198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic Agents for the Treatment of Hypereosinophilic Syndromes.
    Kuang FL; Klion AD
    J Allergy Clin Immunol Pract; 2017; 5(6):1502-1509. PubMed ID: 29122152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.